CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 125 filers reported holding CARA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.74 and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $47,864,000 | 31.00% |
| Chescapmanager LLC | 1,484,303 | $25,382,000 | 4.27% |
| Cypress Capital Management LLC (WY) | 179,920 | $3,077,000 | 3.07% |
| DAFNA Capital Management LLC | 371,033 | $6,345,000 | 1.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $10,715,000 | 0.98% |
| Prosight Management, LP | 86,965 | $1,487,000 | 0.64% |
| ETF MANAGERS GROUP, LLC | 901,714 | $15,419,000 | 0.55% |
| Carmignac Gestion | 2,065,153 | $35,314,000 | 0.49% |
| Ikarian Capital, LLC | 273,524 | $4,677,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $39,330,000 | 0.32% |